drugset

drugset / Trial / NCT00730249

Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA

NCT00730249 ↗

Phase 3 Completed 150 enrolled Medice Arzneimittel Pütter GmbH & Co KG

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Investigation of efficacy of high-dose extended-release Methylphenidate in adults with ADHD, compared with a placebo

Timeline

Start: 2008-09
Primary completion: 2010-01
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Methylphenidate	Small molecule	—	—

Indications